Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Аррей Байофарма Инк.filedCriticalАррей Байофарма Инк.
Priority claimed from PCT/US2006/044431external-prioritypatent/WO2007059257A2/en
Publication of UA97235C2publicationCriticalpatent/UA97235C2/en
This invention provides compounds of Formula (I), wherein B, G, A, E R, R, R, m and n are as defined herein, which are useful as type I receptor tyrosine kinase inhibitors, and methods of use thereof in the treatment of hyperproliferative disorders in mammals.I
UAA200808026A2005-11-152006-11-15Quinazoline and fused pyrimidine derivatives as erbb inhibitors
UA97235C2
(en)
N4-phenyl-quinaz0line-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases